Recruiting

Observational Study

Sponsor:

Salem Anaesthesia Pain Clinic

Code:

NCT05898529

Conditions

COVID-19

Eligibility Criteria

Sex: All

Age: 2 - 17

Healthy Volunteers: Accepted

Interventions

Rapid antigen test

Study Details

Brief summary:

Children infected with COVID-19 are mostly asymptomatic. There is a dearth of data on the epidemiology of COVID-19 in the pediatric population. This is a prospective observational clinical study of pediatric surgical patients. COVID-19 rapid antigen testing will be performed on pediatric patients.

Conditions

COVID-19

Study ID

NCT05898529

Start date

Jul 1, 2023

Status verified date

Jan, 2025

Completion date

Dec 31, 2025

Anticipated

Primary completion date

Dec 31, 2025

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 2 - 17

Healthy Volunteers: Accepted

Inclusion Criteria:

  • surgical patients aged 2-17 years
  • informed consent for surgery
  • no COVID-19 diagnosis in previous 6 months
  • no history of nasal bleeding
  • no history of coagulopathy.

Exclusion Criteria:

  • patient refusal of testing
  • difficulty in obtaining consent
  • COVID-19 diagnosis in recent 6 month
  • history of nasal bleeding
  • history of coagulopathy.

Study Design

Enrollment

350 participants

Anticipated

Interventions and Outcome Measures

Interventions

Rapid antigen test

COVID-19 rapid antigen testing of nasal swab

Primary outcome measure

  • Antigen test positive result [ Time Frame: 1 day ]

Central Contacts and Locations

Central contacts

Olumuyiwa Bamgbade, MD,FRCPC

17786286600olu.bamgbade@gmail.com

Locations

Salem Anaesthesia Pain Clinic

Recruiting

Surrey, British Columbia, Canada, V3S 7J1

Contacts

More Information

Sponsor

Salem Anaesthesia Pain Clinic

Last update posted

Jan 27, 2025

Last verified

Jan, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Salem Anaesthesia Pain Clinic on 2025-01-27.